Bioinformatics Articles

1. iBio Aims To Complement GLP-1s By Preserving Muscle During Weight Loss With Myostatin Antibody 6/25/2026

   iBio has started clinical trials with a long-acting myostatin/GDF11 antibody that can make weight loss healthier and more durable for patients taking GLP-1 agonists.

2. Organizing Digital Systems Around Novel Modalities 6/24/2026

   Cell therapies represent an important advancement in our ability to treat difficult cancers, but continued exploration of this new modality will require new digital tools and equipment.

3. A New De Novo Protein Design Platform For GPCR Drug Discovery 6/9/2026

   Skape Bio and UW created an AI-driven platform to design miniproteins that modulate GPCRs in living cells, opening new paths for biologic drug discovery.

4. Advancing Spatial Multiomics for Discovery: From Promise to Practice 6/5/2026

   Spatial multiomics offers extraordinary biological insight, but high costs, tissue bottlenecks, and unclear clinical relevance still limit its reach.

5. Discovery Dialogues: Winston Haynes, VP, Computational Sciences and Engineering, LabGenius Tx 6/5/2026

   DDO interviewed Winston Haynes, VP, computational sciences and engineering, LabGenius Tx, on their T-cell engagers platform, including its lead candidate LGTX-101, a Nectin-4 CD3 molecule showing strong preclinical efficacy.

6. Discovery Dialogues: Stef van Grieken, CEO, Cradle Bio 6/5/2026

   DDO caught up with Stef van Grieken, CEO of Cradle Bio, which uses AI to speed protein design, putting tools in scientists’ hands. Gains in lead optimization are clear, but safety CMC and tough targets remain key challenges.

7. Why Rare Cancers Are Often Left Behind In Drug Discovery 4/23/2026

   Combining advances in AI with continued investment in rare cancer research could help bring new treatment options to patients who currently have very few.

8. AI: The Inflection Point In Retinal Drug Discovery, Development, And Delivery 4/21/2026

   AI won’t replace clinical or biological insight; instead pairing AI with scientific expertise will sharpen and accelerate retinal therapeutic development.

9. AI, Digitalization, And In Vivo Programming Redefine Cell And Gene Therapy 4/20/2026

   By merging precision genetic engineering with the scalability of nanomedicine and the predictive power of AI, scientists are reshaping the future of human health.

10. Next‑Generation Omics: Latest Insights From A Growing Field 4/8/2026

    Experts share their latest discovery and translational research using multi-omics technologies at the NextGen Omics Spatial & Data conference in Boston.